Novitas MAC A and MAC B Policy Primer 1,2 for Apligraf

Similar documents
Wound Care Charge Process

DERMABOND Portfolio 2012 LACERATION REPAIR REIMBURSEMENT GUIDE

HCPCS AMERIGEL HYDROGEL DRESSINGS CODING GUIDANCE FOR:

Coding & Reimbursement

MEDICAL MANAGEMENT POLICY

Wound and Skin Assessment. Mary Carvalho RN, BSN, MBA Clinical Coordinator Johnson Creek Wound and Edema Center

Claims submission simplified for emergency dental procedure codes

Diabetic Foot Ulcers and Pressure Ulcers. Laurie Duckett D.O. Plastic and Reconstructive Surgeon Oklahoma State University Center for Health Sciences

APPENDIX 1: INTERDISCIPLINARY APPROACH TO PREVENTION AND MANAGEMENT OF DIABETIC FOOT COMPLICATIONS

Integumentary System Individual Exercises

Wound Classification Name That Wound Sheridan, WY June 8 th 2013

7/11/2011. Pressure Ulcers. Moisture-NOT Pressure. Wounds NOT Caused by Pressure

Pressure Ulcer Passport

Provided by the American Venous Forum: veinforum.org

Oklahoma Facts CPT. Definitions. Mohs Micrographic Surgery. What Does That Mean? Billing and Coding for Mohs Surgery

Traumatic Primary Eyelid and Facial Laceration Repair. Riva Lee Asbell Philadelphia, PA

OASIS-C Integument Assessment: Not for Wimps! Part I: Pressure Ulcers

Yes when meets criteria below

the Role of Patricia Turner BSN, RN, CWCN, CWS

Wound Care Management

60889-R5-V1. Billing a Miscellaneous/

Benefit Criteria to Change for Hyperbaric Oxygen Therapy for the CSHCN Services Program Effective November 1, 2012

MEDICAL COVERAGE POLICY. SERVICE: Varicose Veins of the Lower Extremities. PRIOR AUTHORIZATION: Required.

REGION D MEDICARE GROUP 2 PRESSURE REDUCING SUPPORT SUFACE. Documentation Checklist Local Coverage Determination (LCD)

Position Statement: Pressure Ulcer Staging

Dermatology & Wound Care Services

Modifiers Q7, Q8, and Q9

WorryFree DME SM Diabetic Shoe Order Entry Form

CMS Payment Policies (By State)

Meditec.com Free Trial Offer Medical Coding Mini Course. Notice to user:

LCD L C-Reactive Protein High Sensitivity Testing (hscrp)

Physicians as Assistants at Surgery: 2013 Study Participating Organizations:

Pressure Ulcers: Facility Assessment Checklists

Medical Necessity Guidelines: Reconstructive and Cosmetic Surgery

ICD-10 IS COMING OCTOBER 1, 2014

PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)

How To Stage A Pressure Ulcer

Medical Policy Original Effective Date: Revised Date: Page 1 of 8

Pressure Ulcers Assessing and Staging. Anne Pirzadeh RN CWOCN University of Colorado Hospital June 2010

CARE FROM THE INSIDE OUT

Modifiers 25 and 59. Modifier 25

Deborah Rondeau. NY Part B

PROVIDER POLICIES & PROCEDURES

3M Coban 2 Layer Compression Systems

Post-surgical V.A.C. VeraFlo Therapy with Prontosan Instillation on Inpatient Infected Wounds * COLLECTION OF CASE STUDIES

Improving the Compliance of the Annual Foot Examination and Monofilament Testing in

TUTORIAL: How to Code an Emergency Department (ED) Record

Clinical Medical Policy Varicose Vein Treatment

APPLICATION OF DRY DRESSING

Medical Management Program

Venous Reflux Disease and Current Treatments VN20-87-A 01/06

PRA Disclosure Statement

Injection, Tendon Sheath, Ligament, Ganglion Cyst, Carpal and Tarsal Tunnel Supplemental Instructions Article (A47720) Contractor Information

Reimbursement guide. IODOSORB and IODOFLEX are Cadexomer Iodine Dressings which are available in a gel or pad format.

Wound Healing. Healing is a matter of time, but it is sometimes also a matter of opportunity. Hippocrates

Pressure Reducing Support Surfaces - Group 2 (L33642)

Basic Rural Health Clinic Billing

Physicians as Assistants at Surgery: 2016 Update Participating Organizations:

Medicare C/D Medical Coverage Policy

Local Coverage Determination (LCD): Varicose Veins of the Lower Extremities (L31796)

OASIS-C Integument Assessment: Not for Wimps! Part II: Stasis Ulcers and Surgical Wounds

New Outpatient Therapy Evaluation and Intervention E&I Codes. An introduction to the new policy and new claims coding requirements

X-Plain Varicose Veins Reference Summary

INTRODUCTION. The Workers Compensation Act provides in part as follows:

Pulmonary Rehab FAQ s (Abstracted from AACVPR site)

Outpatient Therapy Services

Medicare Policy Regarding Pressure Reducing Support Surfaces JA1014

APPLICATION FOR CHIROPRACTORS PROFESSIONAL LIABILITY INSURANCE (Claims Made and Reported Basis)

Modifiers. Hoda Henein, CHBME, CP President & CEO, Active Management A Practice Management Consulting and Billing Company

Common Pathology Diagnoses: ICD-9 to ICD-10 Mapping

Evaluation and Management Services Documentation and Level of Service

Incident to Billing. Presented by: Helen Hadley VantagePoint Health Care Advisors

Hyperbaric Oxygen Therapy HYPERBARIC OXYGEN THERAPY HS-032. Policy Number: HS-032. Original Effective Date: 7/17/2008

Coding Dermatology Procedures. Presented by: Betty A Hovey Director, ICD-10 Development and Training AAPC

Wound, Ostomy and Continence Nurses Society s Guidance on OASIS-C1 Integumentary Items: Best Practice for Clinicians

Use of a Pressure Ulcer Protocol: Benefits and Recommendations

Negative Pressure Wound Therapy (VAC Therapy) Guidelines

Unraveling the Pressure Ulcer and Wound Care Sections of OASIS-C

Modern Varicose Vein Treatments: What Every Patient Should Know

Plastic, Vascular & Podiatry the Georgetown Model

ICD-10-CM Official Guidelines for Coding and Reporting

Remote Access Technologies/Telehealth Services Medicare Effective January 1, 2016

Medicare Podiatry Services: Information for Medicare Fee-For-Service Health Care Professionals

IPPS Observation vs. Inpatient Admissions Training Questions and Answers

MEDICAL POLICY I. POLICY POLICY TITLE PHYSICAL MEDICINE AND SPECIALIZED PHYSICAL MEDICINE TREATMENTS (OUTPATIENT) POLICY NUMBER MP- 8.

CHAPTER 515 COVERED SERVICES, LIMITATIONS, AND EXCLUSIONS FOR OCCUPATIONAL/PHYSICAL THERAPY SERVICES CHANGE LOG

Subtitle 09 WORKERS' COMPENSATION COMMISSION Guide of Medical and Surgical Fees

Comments and Responses Regarding Draft Local Coverage Determination: Outpatient Physical and Occupational Therapy Services

Daman Published Rates

Contractor Number Oversight Region Region IV

ICD 10 ESSENTIALS. Debbie Sarason Manager, Practice Enhancement and Quality Reporting

Wound Care: The Basics

Emory Healthcare s model for a PA based vein clinic

Carol Novak, RN, CHC Martin Yuson, DPT, JD. Tips for Effective Auditing/Monitoring of Medicare Documentation for OT, PT and Speech 4/24/2013

Local Coverage Determination (LCD): Non-Vascular Extremity Ultrasound (L34716)

Central Office N/A N/A

SPORTS INSURANCE PROPOSAL FORM (All questions must be answered in ink)

FUNCTIONS OF THE SKIN

WOUND OSTOMY CONTINENCE NURSES SOCIETY GUIDANCE ON OASIS-C INTEGUMENTARY ITEMS

Comprehensive Error Rate Testing (CERT) Help Prevent Pathology and Laboratory Errors

Transcription:

Novitas MAC A and MAC B Policy Primer 1,2 for Apligraf DC, DE, MD, NJ & PA Counties of Arlington and Fairfax in Virginia and the city of Alexandria in Virginia are covered under this policy primer Effective Date: 1/1/2012 Indications VSU 3 The ulcer(s) is of at least four (4) weeks in duration. The treatment is specific to non-infected partial or full-thickness skin ulcers, at least 1.0 cm 2 in size, due to clinically documented venous insufficiency (venous insufficiency should be objectively documented either by history of previous deep venous thrombosis in the index leg, or objective documentation of valvular reflux by duplex ultrasound, venography, or air/photo plethysmography). Adequate circulation/oxygenation is supported by documented physical examination and an Ankle-Brachial Index (ABI) of no less than 0.65 DFU 4 The ulcer is of at least three (3) weeks in duration. The treatment is specific to non-infected full thickness foot ulcers, at least 1.0 cm 2 in size, due to clinically documented diabetic neuropathy (type 1 or type 2 diabetes should be objectively documented as well as the current medical management for the diabetes. The ulcer is located on the surface of the foot and is free of infection, tunnels, and tracts. Additionally, the ulcer must be free of cellulitis, eschar, or obvious necrotic material as this will interfere with the device adherence and wound healing. The ulcer extends through the dermis but it does not involve the tendon, muscle, capsule or have bone exposure. Limitations Because application of Apligraf, and Dermagraft, as well as any subsequently accepted similar product, is considered a physician service, these products must be applied by a physician or a qualified licensed Non-Physician Practitioner and not by non-advanced practice nurses, therapists or medical assistants. The application of Apligraf is limited to clinicians who are highly skilled in wound care management and have experience in the use of HSE for the treatment of wounds. The success of the procedure is somewhat dependent on the skill of the performing provider; therefore, the provider may be subject to a post payment peer review in order to verify his/her qualifications. Note: The liberalization of this provision of the LCD to allow clinicians other than physicians (MD, DO, and DPMs), as well as physicians (MD, DO, and DPMs) who are highly skilled in wound care management and have experience in the use of HSE for the treatment of wounds, is retroactive to 12/13/2008. Prior to Apligraf application, it is expected the medical record documentation will contain evidence that the conservative measures have failed, or the medical record supports that the ulcer is so clinically severe that it requires immediate, aggressive therapy. The medical record

Novitas MAC A and MAC B Policy Primer 1,2 for Apligraf (continued) must reflect that the ulcer has failed to decrease in size and depth, or that there has been no change in baseline size or depth with no sign of improvement, or no indication that improvement is likely. A single application of Apligraf may be all that is required to affect the wound healing in those wounds that are likely to improve by this therapy. The use of additional applications if less than 50% take is observed, is limited to a total of four additional applications for the same ulcer (so a total of five). Additional applications beyond this for one year are generally not considered reasonable and necessary. Retreatment within one year following the last successful Apligraf application is generally not considered reasonable and necessary. Retreatment of an ulcer following the unsuccessful treatment where is consisted of two failed Apligraf applications is not considered reasonable and necessary. Documentation All documentation must be maintained in the patient s medical record and available to the contractor upon request. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service(s)). The record must include the physician or non-physician practitioner responsible for and providing the care of the patient. The submitted medical record should support the use of the selected ICD-9-CM code(s). The submitted CPT/HCPCS code should describe the service performed. The medical record should clearly reflect the post-application care and the effectiveness of the device. Product Wastage Documentation Requirements Any amount of wasted material must be clearly documented in the medical record with the following information: Date, time and location of ulcer treated. Approximate amount of product unit used. Approximate amount of product unit discarded. Reason for the wastage. Manufacturer s serial/lot/batch or other unit identification number of graft material. When manufacturer does not supply unit identification, record must document such. Coding Product Wastage (JW Modifier) HCPCS modifier: JW may be used to indicate the product amount discarded and not used on any patient. The amount used must be on a separate detail line from the amount wasted, which is indicated with modifier -JW (when applicable). Modifier -JW would not be used for claims billing when the product code description already includes the amount administered along with the amount wasted.

Novitas MAC A and MAC B Policy Primer 1,2 for Apligraf (continued) Coding CPT/HCPCS 5 Q4101: Apligraf, per square centimeter Application Codes for Leg 15271: Application of skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area 15272: Application of skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (List separately in addition to code for primary procedure) 15273: Application of skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area 15274: Application of skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part therof (List separately in addition to code for primary procedure) Application Codes for Foot 15275: Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area 15276: Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (List separately in addition to code for primary procedure) 15277: Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area 15278: Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part therof (List separately in addition to code for primary procedure) K Modifier When application of the material is accomplished by the use of sutures, staples, steri-strips, or other techniques per product instruction, report the applicable CPT procedure code, the applicable HCPCS Q code for the product, and modifier K. Use of the modifier K indicates that the documentation in the medical record supports the use of a method of affixing the HSE beyond a dressing only. That documentation is to be retained in the medical record and submitted to the contractor upon request. ICD-9-CM VSU: 454.0, 454.2, 707.10-707.15, 707.19 DFU: 707.14, 707.15 1 Source: www.cms.com 2 This document is for informational purposes only. Use of this information does not guarantee coverage or payment for these services by Medicare or other payors. Physicians and other providers should use independent judgment when selecting codes that most appropriately describe the services provided to a patient. Physicians and hospitals are solely responsible for compliance with Medicare and other payors laws, rules, and requirements. 3 VSU = Venous Stasis Ulcer. 4 DFU = Diabetic Foot Ulcer. 5 CPT American Medical Association. All Rights Reserved.

2014 Novitas Medicare Apligraf Sample UB-04 Claim Form Anytown Hospital 123 Medical Drive Anytown, NJ 00000 01011935 HIC 012345678A 01-2345678 01012014 01012014 111 Maple Avenue Anytown NJ 00000 131 All dates should be in eight digit format. Jane Smith 111 Maple Avenue Anytown, NJ 00000 636 Apligraf Q4101 K 01012014 30 Apligraf product wastage Q4101 K JW 14 360 Application, first 25 sq cm 15271 K 01012014 1 360 Application, each additional 25 sq cm 15272 K 01012014 1 Enter appropriate revenue codes for all services provided. Revenue code 636 should be used when billing for Apligraf. 15271 and 15272 should be used based on the size of the wound. For example, a LEG wound measuring 30 sq cm, would be billed using 15271 (first 25 sq cm or less) and 15272 (each additional 25 sq cm or part thereof). Apligraf is supplied in 44 sq cm and is for single use. This example is for a 30 sq cm wound with 14 sq cm coded for wastage with the JW modifier. Medicare A987654 xxx.xx VSU: 454.0, 454.2, 707.10-707.15, 707.19 DFU: 707.14, 707.15

2014 Novitas Medicare Apligraf Sample CMS-1500 Claim Form Physician Services in an Outpatient Setting 123-45-6789A 12 13 35 123 Any Street 123 Any Street Anytown NY Anytown NY 00000 (973) 555-1234 00000 973 555-1234 SIGNATURE ON FILE xxx xx xxx xx VSU: 454.0, 454.2, 707.10-707.15, 707.19 DFU: 707.14, 707.15 01 01 14 01 01 14 22 15271 K 01 01 14 01 01 14 22 15272 K 15271 and 15272 should be used based on the size of the wound. For example, a LEG wound measuring 30 sq cm, would be billed using 15271 (first 25 sq cm or less) and 15272 (each additional 25 sq cm or part thereof). 01-2345678 012345678

2014 Novitas Medicare Apligraf Sample CMS-1500 Claim Form Physician Services in an Office Setting 123-45-6789A 12 13 35 123 Any Street 123 Any Street Anytown NY Anytown NY 00000 (973) 555-1234 00000 973 555-1234 SIGNATURE ON FILE xxx xx xxx xx VSU: 454.0, 454.2, 707.10-707.15, 707.19 DFU: 707.14, 707.15 01 01 14 01 01 14 11 Q4101 K Q4101 K JW 01 01 14 01 01 14 11 15271 K 01 01 14 01 01 14 11 15272 K 30 14 15271 and 15272 should be used based on the size of the wound. For example, a LEG wound measuring 30 sq cm, would be billed using 15271 (first 25 sq cm or less) and 15272 (each additional 25 sq cm or part thereof). Apligraf is supplied in 44 sq cm and is for single use. This example is for a 30 sq cm wound with 14 sq cm coded for wastage with the JW modifier. 01-2345678 012345678

Model Documentation Form for Novitas JL for Apligraf Pretreatment: 1. Duration of ulcer (DFU: 3 weeks, VSU: greater than 1 month) weeks 2. Location of ulcer 3. Document failure to respond to conservative measures (a failed response is defined as an ulcer that has increased in size or depth and no indication that improvement is likely e.g., epithelial in growth and progression towards closure) 4. If Apligraf is being utilized for an immediate need (without a history of failure to respond to conservative measures) document whether the ulcer is so clinically severe that it requires immediate, aggressive therapy. 5. Document measurement of the ulcer at baseline, following cessation of conservative management. 6. Describe treatment of the underlying disease process contributing to the ulcer 7. Indicate appropriate patient diagnosis codes: VSU: 454.0, 454.2, 707.10-707.15, 707.19 DFU: 707.14, 707.15 8. Document whether wound is clean, free of cellulitis, infection, tunnels and tracts, eschar or any necrotic material 9. For DFU, document whether ulcer extends through the dermis but without tendon, muscle, capsule or bone exposure. 10. For DFU, document the neuropathy. Continued on next page > This document is for informational purposes only. Use of this information does not guarantee coverage or payment for these services by Medicare or other payors. LCDs are updated by Medicare and Medicare contractors on a regular basis. Physicians and other providers should regularly refer to the applicable Medicare local coverage determinations (LCDs) for complete information on medical necessity documentation requirements. Physicians, providers and hospitals are solely responsible for compliance with Medicare and other payors laws, rules, and requirements.

11. Document patient s arterial blood supply as evidenced by ABI (ABI of 0.65 or greater) 12. For venous insufficiency ulcer, document venous insufficiency (either by history of previous deep venous thrombosis in the index leg, or objective documentation of valvular reflux by duplex ultrasound, venography, or air/photo plethysmography) 13. Document that the patient is competent, and/or has the support services required to participate in follow-up care associated with the treatment of the wound following Apligraf application. Treatment: 14. Document measurement of ulcer (width and length or circumference and depth) immediately prior to application of Apligraf sq cm 15. Document whether this is an initial application of Apligraf or a reapplication. (Apligraf is limited to 5 applications per ulcer.) 16. For Apligraf reapplications, document whether less than 50% take is observed 17. Document how Apligraf was fixated to the wound (Use of the K modifier indicates that the documentation supports the use of a method of affixing Apligraf beyond a dressing only). 18. Document the name of the physician treating the patient s systemic disease and how the patient s systemic disease is being treated/monitored in order to insure adequate healing of the wound site. 19. Describe post-application patient care Product Wastage Documentation Requirements: 20. Date: 21. Time: 22. Location of ulcer: 23. Approximate amount of product unit used: 24. Approximate amount of product unit discarded: 25. Reason for the wastage: 26. Manufacture s serial/lot/batch number Wastage example of 30sq cm wound that was treated with Apligraf (Apligraf is supplied in 44 sq cm) Q4101 K - 30units Q4101 K JW - 14 units This document is for informational purposes only. Use of this information does not guarantee coverage or payment for these services by Medicare or other payors. LCDs are updated by Medicare and Medicare contractors on a regular basis. Physicians and other providers should regularly refer to the applicable Medicare local coverage determinations (LCDs) for complete information on medical necessity documentation requirements. Physicians, providers and hospitals are solely responsible for compliance with Medicare and other payors laws, rules, and requirements.